Roche (ROG) PT Set at CHF 275 by Bank of America

Roche (VTX:ROG) received a CHF 275 price target from investment analysts at Bank of America in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the healthcare company’s stock. Bank of America’s price target would suggest a potential upside of 13.50% from the stock’s current price.

A number of other analysts also recently commented on the company. Deutsche Bank set a CHF 255 target price on Roche and gave the stock a “neutral” rating in a research note on Monday, September 11th. Berenberg Bank set a CHF 260 target price on Roche and gave the stock a “neutral” rating in a research note on Tuesday, October 24th. J P Morgan Chase & Co restated a “buy” rating on shares of Roche in a research note on Monday, October 9th. Morgan Stanley set a CHF 260 target price on Roche and gave the stock a “neutral” rating in a research note on Friday, October 6th. Finally, Jefferies Group set a CHF 295 target price on Roche and gave the stock a “buy” rating in a research note on Monday, October 16th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of CHF 261.32.

Shares of Roche (VTX ROG) opened at CHF 242.30 on Wednesday. Roche has a one year low of CHF 219.10 and a one year high of CHF 273.

ILLEGAL ACTIVITY WARNING: “Roche (ROG) PT Set at CHF 275 by Bank of America” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/12/08/roche-rog-pt-set-at-chf-275-by-bank-of-america.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

What are top analysts saying about Roche Holding Ltd.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Roche Holding Ltd. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit